Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study

Fig. 1

Changes of the tumor immune microenvironment induced by neoadjuvant chemotherapy. a, b Changes from biopsy (pre-neoadjuvant) to surgical tissue sample (post-neoadjuvant) for each patient, in all cases (left), in the no-pCR (middle), and in the pCR groups (right), for tumor-infiltrating lymphocytes (TILs) and TIM-3, respectively. c, d Comparison of changes from pre-neoadjuvant to post-neoadjuvant (as % change) between the no-pCR and the pCR groups, for TILs and LAG-3, respectively

Back to article page